Richard B Kim

Richard B Kim

Western University

H-index: 98

North America-Canada

About Richard B Kim

Richard B Kim, With an exceptional h-index of 98 and a recent h-index of 45 (since 2020), a distinguished researcher at Western University, specializes in the field of Personalized Medicine, Clinical Pharmacology, Pharmacogenetics, Drug Transporters, Drug Metabolism.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cost-effectiveness analysis of pharmacogenomics (PGx)-based warfarin, apixaban, and rivaroxaban versus standard warfarin for the management of atrial fibrillation in Ontario …

Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis

Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory …

Patients’ Experiences of a Precision Medicine Clinic

Allopurinol hypersensitivity syndrome: Raising awareness of an uncommon but potentially serious adverse event among kidney stone patients

Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort

High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic …

HLADQA1∗ 05G> A Genetic Screening Promotes the Safe Delivery of Combination Therapy in Inflammatory Bowel Disease

Richard B Kim Information

University

Position

___

Citations(all)

39531

Citations(since 2020)

8589

Cited By

34944

hIndex(all)

98

hIndex(since 2020)

45

i10Index(all)

244

i10Index(since 2020)

173

Email

University Profile Page

Western University

Google Scholar

View Google Scholar Profile

Richard B Kim Skills & Research Interests

Personalized Medicine

Clinical Pharmacology

Pharmacogenetics

Drug Transporters

Drug Metabolism

Top articles of Richard B Kim

Title

Journal

Author(s)

Publication Date

Cost-effectiveness analysis of pharmacogenomics (PGx)-based warfarin, apixaban, and rivaroxaban versus standard warfarin for the management of atrial fibrillation in Ontario …

Pharmacoeconomics

Aneeka Hafeez

Lauren E Cipriano

Richard B Kim

Gregory S Zaric

Ute I Schwarz

...

2024/1

Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis

The European Journal of Health Economics

Michael Situ

Ute I Schwarz

Guangyong Zou

Eric McArthur

Richard B Kim

...

2024/4

Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory …

Journal of the Canadian Association of Gastroenterology

Cheng-Chun Tai

Samantha Medwid

Keith Mclntosh

Nilesh Chande

Richard B Kim

...

2024/2/10

Patients’ Experiences of a Precision Medicine Clinic

Journal of Patient Experience

David Barrett

Jovana Sibalija

Richard B Kim

2024/2

Allopurinol hypersensitivity syndrome: Raising awareness of an uncommon but potentially serious adverse event among kidney stone patients

Tariq Alotaibi

Jennifer Bjazevic

Richard Kim

Steven Gryn

Nabil Sultan

...

2024/1/30

Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort

Pharmacogenetics and Genomics

Samantha J Medwid

Jaymie L Mailloux

Theodore J Wigle

Richard B Kim

2024/4/1

High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic …

Canadian Journal of Kidney Health and Disease

Sheikh S Abdullah

Neda Rostamzadeh

Flory T Muanda

Eric McArthur

Matthew A Weir

...

2024/1

HLADQA1∗ 05G> A Genetic Screening Promotes the Safe Delivery of Combination Therapy in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Aze Wilson

Nilesh Chande

Terry Ponich

James C Gregor

Yun-Hee Choi

...

2024/4/1

Uptake Transporters

Samantha Medwid

Richard H Ho

Richard B Kim

2023/1/1

Expression and localization of efflux drug transporters P-glycoprotein and breast cancer resistance protein (BCRP) in adult human pancreatic islet alpha and beta cells

Jihoon Kwon

Jaehyun Hwang

Michelle S Kim

Rommel G Tirona

Richard B Kim

...

2023/5/19

Fluoropyrimidine-associated toxicity and DPYD variants c. 85T> C, c. 496A> G, and c. 1236G> A: impact of haplotype

Cancer Chemotherapy and Pharmacology

Samantha Medwid

Theodore J Wigle

Richard B Kim

2023/1

Olopatadine/Mometasone (Ryaltris) for Allergic Rhinitis

Medical Letter on Drugs and Therapeutics

Mark Abramowicz

Jean Marie Pflomm

Susan M Daron

Amy Faucard

Michael P Viscusi

...

2023

Abstract CT032: Trials in progress: a global phase 1/1b clinical trial evaluating exarafenib (KIN-2787), a highly selective pan-RAF inhibitor, in adult patients with BRAF …

Cancer Research

Alexander Spira

Valentina Gambardella

Shumei Kato

Cesar Batista Perez

Meredith Mckean

...

2023/4/14

Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease

JAMA Network Open

Flory T Muanda

Peter G Blake

Matthew A Weir

Fatemeh Ahmadi

Eric McArthur

...

2023/11/1

Proactive therapeutic drug monitoring of adalimumab in patients with crohn’s disease

Journal of Crohn's and Colitis

Konstantinos Papamichael

Anna Juncadella

Danny Wong

Shana Rakowsky

Lindsey A Sattler

...

2019/8/14

Topical Roflumilast (Zoryve) for Plaque Psoriasis

Medical Letter on Drugs and Therapeutics

Mark Abramowicz

Jean Marie Pflomm

Susan M Daron

Amy Faucard

Michael P Viscusi

...

2023

TPMT intermediate metabolizer status and thiopurine-associated toxicity during maintenance therapy in childhood acute lymphoblastic leukemia.

Clinical Pharmacology and Therapeutics

UI Schwarz

M Woldanski-Travaglini

V Swanston

M Mikhail

C Cacciotti

...

2023/3/18

Genetic variation in miR-27a is associated with fluoropyrimidine-associated toxicity in patients with dihydropyrimidine dehydrogenase variants after genotype-guided dose reduction

International Journal of Molecular Sciences

Samantha Medwid

Theodore J Wigle

Cameron Ross

Richard B Kim

2023/8/27

Decreased infliximab concentrations in patients with inflammatory bowel disease who carry a variable number tandem repeat polymorphism in the neonatal Fc receptor or variant …

Inflammatory Bowel Diseases

Bethany Choi

Michael Sey

Terry Ponich

Melanie Beaton

Richard Kim

...

2023/3/1

Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study

Health Science Reports

Kevin Yau

Eric McArthur

Nivethika Jeyakumar

Flory Tsobo Muanda

Richard B Kim

...

2023/6

See List of Professors in Richard B Kim University(Western University)

Co-Authors

H-index: 175
Fred Guengerich

Fred Guengerich

Vanderbilt University

H-index: 154
Dan Roden

Dan Roden

Vanderbilt University

H-index: 131
Rob Hegele

Rob Hegele

Western University

H-index: 103
Alfred L. George, Jr.

Alfred L. George, Jr.

North Western University

academic-engine